Insider · CIK 0001729505
Mpm Bioventures 2018, L.p.
Files at TRDA (Entrada Therapeutics, Inc.), ITOS (iTeos Therapeutics, Inc.). First filing Dec 12, 2024, latest Sep 9, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TRDA: Entrada Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | Entrada Therapeutics, Inc. | $1.9M 259,837 shares | -6% | - | |
| 40Moderate | Entrada Therapeutics, Inc. | $617k 86,482 shares | -2% | - | |
| 53Moderate | iTeos Therapeutics, Inc. | $5.1M 630,191 shares | -23% | - | |
| 51Moderate | Entrada Therapeutics, Inc. | $917k 44,722 shares | -1% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -38,500 | $7.11 | $274k | 4,106,452 | 33 d ago |
| Sep 8, 2026 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -192,500 | $7.41 | $1.4M | 3,913,952 | 33 d ago |
| Sep 9, 2026 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -28,837 | $7.13 | $206k | 3,885,115 | 33 d ago |
| Sep 1, 2026 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -29,088 | $7.06 | $205k | 4,202,346 | 39 d ago |
| Sep 2, 2026 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -25,131 | $7.19 | $181k | 4,177,215 | 39 d ago |
| Sep 3, 2026 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -32,263 | $7.17 | $231k | 4,144,952 | 39 d ago |
| May 13, 2025 | ITOS iTeos Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -630,191 | $8.06 | $5.1M | 2,108,594 | May 15, 2025 |
| Dec 10, 2024 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -22,935 | $20.77 | $476k | 4,402,849 | Dec 12, 2024 |
| Dec 11, 2024 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -21,787 | $20.23 | $441k | 4,381,062 | Dec 12, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.